Reduced anaerobic glycolysis in oral contraceptive users
Vijayalakshmi, R.; Bamji, M.S.; Ramalakshmi, B.A.
Contraception 38(1): 91-97
1988
ISSN/ISBN: 0010-7824 PMID: 2971503 DOI: 10.1016/0010-7824(88)90098-4Document Number: 357947
Oral contraceptives containing combinations of estrogens and progestogens are known to impair glucose tolerance. The biochemical mechanisms underlying this lesion are speculative. In the present study women treated with OC for periods exceeding 10 cycles showed significant reduction in the activity of the key glycolytic enzyme phosphofructokinase (40%) and the levels of lactate (42%) in the erythrocytes compared to controls. These observations in women are analogous to those made earlier in female rats.
Document emailed within 0-6 h
Related Documents
Bushman, B.; Masterson, G.; Nelsen, J. 2006: Anaerobic power performance and the menstrual cycle: eumenorrheic and oral contraceptive users Journal of Sports Medicine and Physical Fitness 46(1): 132-137Lee, H.; Petrofsky, J.S.; Daher, N.; Berk, L.; Laymon, M. 2014: Differences in anterior cruciate ligament elasticity and force for knee flexion in women: oral contraceptive users versus non-oral contraceptive users European Journal of Applied Physiology 114(2): 285-294
Lee, H.; Petrofsky, J.S.; Daher, N.; Berk, L.; Laymon, M. 2014: Differences in anterior cruciate ligament elasticity and force for knee flexion in women: oral contraceptive users versus non-oral contraceptive users European Journal of Applied Physiology 114(2): 285-294
Krings, K.M.; Matteson, K.A.; Allsworth, J.E.; Mathias, E.; Peipert, J.F. 2008: Contraceptive choice: how do oral contraceptive users differ from condom users and women who use no contraception? American Journal of Obstetrics and Gynecology 198(5): E46-E47
Krings, K.M.; Matteson, K.A.; Allsworth, J.E.; Mathias, E.; Peipert, J.F. 2008: Contraceptive choice: how do oral contraceptive users differ from condom users and women who use no contraception? American Journal of Obstetrics and Gynecology 198(5): E46-E47
Krings, K.M.; Matteson, K.A.; Allsworth, J.E.; Mathias, E.; Peipert, J.F. 2008: Contraceptive choice: how do oral contraceptive users differ from condom users and women who use no contraception? American Journal of Obstetrics and Gynecology 198(5): E46-E47
Boonsiri, B.; Kolkijkovinda, S.; Chutivongse, S.; Crona, N.; Medberg, M.; Gundersen, G.; Samsioe, G.; Garza-Flores, J.; Valles de Bourges, V.; Juarez-Ayala, J. 1988: A multicentre comparative study of serum lipids and lipoproteins in four groups of oral combined contraceptive users and a control group of IUD users. World Health Organization. Task Force on Oral Contraceptives Contraception 38(6): 605-629
Kaul, L.; Ahluwalia, B. 1978: Interrelation of caffeine and oral contraceptive steroid metabolism in hypertensive oral contraceptive users in humans Journal of Steroid Biochemistry 9(9): 862-863
Heithecker, R.; Laengner, H. 1979: Field tests with an oral contraceptive. Results with an estrogen-reduced contraceptive for the sympton of "tight breast" Zfa. Zeitschrift für Allgemeinmedizin 55(29): 1665-1666
Jensen, J.T.; Archer, D.F.; Westhoff, C.L.; Nelson, A.L.; Graham, S.; Bernick, B. 2023: Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring Users Journal of Women's Health 32(7): 808-815
McVay, M.A.; Copeland, A.L.; Geiselman, P.J. 2011: Eating disorder pathology and menstrual cycle fluctuations in eating variables in oral contraceptive users and non-users Eating Behaviors 12(1): 49-55
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives : levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception (Stoneham) 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives : levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception (Stoneham) 74(4): 290-292